39512-48-6Relevant articles and documents
PHENYL- SULFONYL DERIVATIVES AS MEDIATORS OF TRPA1 RECEPTOR ACTIVITY FOR THE TREATMENT OF PAIN
-
Page/Page column 45, (2012/12/13)
Compounds of formula I, wherein A and R1-R7, are as defined in the claims, exhibit TRPA1 activity and useful as TRPA1 modulators.
1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
-
Page 75, (2010/02/06)
Certain 1-(aromatic- or heteroaromatic-substituted-3-(heteroaromatic substituted)-1,3-propanediones are described as inhibitors of HIV integrase and inhibitors of HIV replication. These compounds are useful in the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
PROTEASE-BINDING COMPOUNDS AND METHODS OF USE
-
, (2008/06/13)
Non-peptide, protease-binding compounds are described as useful in the detection, labelling, and inhibition of retroviral proteases. Aryl piperidinyl derivatives and other compounds related in structure have been found to be HIV-1 and HIV-2 protease-binding compounds.
Imidazo[1,2-a]pyridines, and process for their preparation
-
, (2008/06/13)
This invention relates to novel substituted imidazo[1,2-a]pyridines, most especially novel 8-phenylimidazo[1,2-a]pyridines and a process for their preparation. The compounds of the invention have been found to have cardiotonic antiarrhythmic, CNS stimulant, CNS depressant and other pharmacological effects.
